Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomedical Research (Japan) is Scopus-indexed (Q3, CiteScore 2.2), WoS SCIE. Published by Biomedical Research Foundation.
Checked against the index lists dated .
ISSN 0388-6107Verify ISSN ↗1880-313XVerify ISSN ↗
Publisher: Biomedical Research Foundation
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (all) | 142 / 223 | 36th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1980–present, best quartile Q3, CiteScore 2.2.
Biomedical Research (Japan) is Q3 in Biochemistry, Genetics and Molecular Biology (all) (rank 142 of 223), by CiteScore 2025.
Biomedical Research (Japan) is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.2, which places it in quartile Q3 at the 36th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.387, quartile Q3, with an H-index of 46.
Biomedical Research (Japan) is published by Biomedical Research Foundation. Its print ISSN is 0388-6107 and its online ISSN is 1880-313X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biomedical Research (Japan) has an h-index of 62 and a 2-year mean of 1.89 citations per paper (OpenAlex). Its Scopus CiteScore is 2.2, quartile Q3. On 2-year citations it ranks #106 of 221 Scopus journals in Biochemistry, Genetics and Molecular Biology (all).
Biomedical Research (Japan) published 29 papers in 2025; its busiest recent year was 2019 with 155. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2022–2026), authors are most often from Japan (87.5%), China (7.5%) and United States (1.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.